Neurology Today in 5

Small fiber neuropathy, Dr. Merit Cudkowicz, work-life balance for families of neurologists

Divisive treatment for cluster headache, head positioning before thrombectomy, new series, “Neurology in America”

New treatment for giant-cell arteritis, links between oral and brain health, an emerging meningitis B vaccine

Telomere length and and risk for neurologic disorders, impact of research cuts on promotion/tenure, herpes zoster vaccine and dementia

Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.

Post-TIA fatigue, neurologic complications of measles, CDC surveillance of epilepsy program dismantled.

Advances in cell therapies for Parkinson’s, GLP-1 agonists and dementia risk, FDA accelerated approvals for neurology drugs

Microplastics in brain, salary gap in neurology, the neurology of space

Impact of high-dose Vitamin D on MS relapse, the role of AI in neurology education, and a 4D animal model that shows precursors of MS lesions before they appear.

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting

Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists

IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.

Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.

Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s

Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression

Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder

Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke

Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism

Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice

Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer

Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology

When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.

Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics

Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers

Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies

ME/CFS and long COVID; negative outcomes for ALS drug; donanemab

BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine

SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens

AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy

Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders

Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions

Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury

DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023

Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.

Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans

A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.

Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease

Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer’s

Football and Parkinson’s, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients

Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.

Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.

Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.

Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke